11621264ACTIVE
Incorporated: 2018-10-14
SIC: 72110
Last updated: 15 Jun 2026
NovalGen develops bispecific and multi‑specific antibody therapeutics that harness the immune system Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-06-15 | £11k |
Companies with the most similar business descriptions.